
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 August 9
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Develop and execute a global training strategy tailored to cell therapy programs across clinical and commercial stages • Build role-specific onboarding, certification, and continuous learning pathways for Medical and Commercial teams • Design and develop training content while overseeing and leveraging external vendors • Deliver training on disease state education, unmet medical needs, CAR T product design and manufacturing, clinical data, safety monitoring and management, and competitive landscape • Plan and lead virtual and onsite onboarding and refresher programs • Partner cross-functionally with Medical Affairs, Clinical Development, CMC, Regulatory, Quality, Commercial, and Patient Services • Ensure training materials and certification processes meet FDA, EMA, and global compliance standards • Develop learning systems and training analytics, including KPIs for competency, certification, and launch preparedness • Partner with HR on company-wide onboarding programs for new employee orientation
• Advanced degree required (APN, PharmD, PhD, MD, or equivalent) • 10+ years in biotechnology or pharmaceutical industry • Minimum 5 years in Medical Affairs leadership or Medical Training roles • Direct experience in cell therapy and/or gene therapy strongly preferred • Neuroscience, neurology, and/or immunology experience strongly preferred • Experience supporting launch of advanced therapies strongly preferred • Strong knowledge of regulatory and compliance frameworks in advanced modalities • Demonstrated ability to build infrastructure in clinical-stage or scaling biotech environments • Excellent communication skills, cross-functional partnership, and ability to manage complexity in fast-paced, resource-conscious environments
• Eligible for bonus • Benefits • Participation in Company’s stock plan • Approximately 15% travel
Apply Now🕒 August 8
National Facilities Director overseeing ClearSky Health’s hospital infrastructure, Environment of Care, and regulatory compliance. Leading modernization, safety, emergency preparedness, and facilities leadership across multiple healthcare locations.
🕒 August 8
Group Patient Care Director leading veterinary technician and assistant teams across VCA Animal Hospitals. Improving patient safety, clinical quality, associate development, and hospital performance across the North Atlantic region.
🕒 August 8
Technical Director leading national Facility Condition Assessment and regulatory audit services for JLL’s commercial real estate due diligence business. Driving strategy, client growth, quality, operations, and multidisciplinary team leadership across Asset Services.
🕒 August 8
Director shaping national talent attraction and employer branding for Pinnacle Live, an in-house audiovisual and event-production company. Building recruiting strategy, pipelines, systems, and teams across U.S. venues.
🕒 August 7
Managing Director leading AI strategy, innovation, and implementation for ILO Group’s K–12 education clients. Developing client deliverables, advising education leaders, and building scalable responsible-AI systems.